Sales revenue

Operating income before special items

Operating income

Net income attributable to owners of the parent

(Million ¥)

FY2019FY2020FY2021FY2022FY2023
Sales revenueFull Year1,349,5221,211,7251,612,6881,879,5471,749,743
3rd Q1,005,254857,4281,165,0791,428,9111,274,530
2nd Q678,664536,979743,535951,077823,655
1st Q345,003254,484370,591476,113407,925
Operating income
before special items
Full Year72,33085,140161,815113,90396,234
3rd Q59,94552,180134,260110,34972,376
2nd Q39,77318,57494,27677,55342,016
1st Q24,53358351,94044,58020,926
Operating incomeFull Year64,56978,074147,310128,99874,124
3rd Q55,24951,927138,624107,01860,023
2nd Q36,86317,90196,55072,50831,245
1st Q22,117-4853,22742,94913,887
Net income attributable
to owners of
the parent
Full Year33,97057,873109,99082,93649,999
3rd Q30,97433,001102,66564,94637,261
2nd Q20,3619,60275,99144,35320,687
1st Q12,533-2,31842,62427,9929,591

Note: Mitsui Chemicals, Inc. finalized the provisional accounting treatment for the business combination at the end of FY2021. Operating income and net income attributable to owners of the parent for the 2nd and 3rd quarters of FY2021 reflect the revision of the initially allocated amounts of acquisition cost as the Company finalized the provisional accounting treatment for the business combination.

FY20XX indicates the fiscal year starting on April 1, 20XX and ending on March 31, 20XX+1.